MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 29 October 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.01065-07v1
28/1/237    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, J. C.
Right arrow Articles by Duckett, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, J. C.
Right arrow Articles by Duckett, C. S.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.01065-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

AIF IS A TARGET FOR UBIQUITINATION THROUGH INTERACTION WITH XIAP

John C. Wilkinson, Amanda S. Wilkinson, Stefanie Galbán, Rebecca A. Csomos, and Colin S. Duckett*

Departments of Pathology, and Internal Medicine, University of Michigan, Ann Arbor, MI, 48109

* To whom correspondence should be addressed. Email: colind{at}umich.edu.


   Abstract

X-linked inhibitor of apoptosis (XIAP) is an inhibitor of apoptotic cell death that protects cells by caspase-dependent and independent mechanisms. In a screen for molecules that participate with XIAP in regulating cellular activities, we identified AIF (apoptosis inducing factor) as an XIAP binding protein. BIR2 of XIAP is sufficient for the XIAP/AIF interaction, which is disrupted by Smac/DIABLO. In healthy cells, mature human AIF lacks only the first 54 amino acids, differing significantly from the apoptotic form which lacks the first 102 amino-terminal residues. Fluorescence complementation and immunoprecipitation experiments revealed that XIAP interacts with both AIF forms. AIF was found to be a target of XIAP-mediated ubiquitination under both normal and apoptotic conditions, and an E3 ubiquitin ligase deficient XIAP variant displayed a more robust interaction with AIF. Expression of either XIAP or AIF attenuated both basal and antimycin A stimulated levels of reactive oxygen species (ROS), and when expressed in combination, a cumulative decrease in ROS was observed. These results identify AIF as a new XIAP binding partner, and indicate a role for XIAP in regulating cellular ROS.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.